Cargando…

Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of coronary artery disease (CAD) above the baseline. Baicalin possesses beneficial effects against both RA and CAD, but little is know on its clincial efficacy among patients manifesting both CAD and RA. METHODS: Three hundre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hang, Yuanxing, Qin, Xian, Ren, Tianli, Cao, Jianing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015450/ https://www.ncbi.nlm.nih.gov/pubmed/29935544 http://dx.doi.org/10.1186/s12944-018-0797-2

Ejemplares similares

Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study
por: Kolahi, Sousan, et al.
Publicado: (2015)

A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis
por: de los Angeles Pineda, Maria, et al.
Publicado: (2011)

A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis
por: Sahebari, Maryam, et al.
Publicado: (2021)

Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
por: Buondonno, Ilaria, et al.
Publicado: (2017)

Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial
por: Cohen, Stanley, et al.
Publicado: (2020)

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
por: Smolen, J S, et al.
Publicado: (2015)

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
por: Izumi, Yasumori, et al.
Publicado: (2017)

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
por: Buttgereit, Frank, et al.
Publicado: (2019)

Baicalin Inhibits IL-17-Mediated Joint Inflammation in Murine Adjuvant-Induced Arthritis
por: Yang, Xue, et al.
Publicado: (2013)

Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis
por: Smith, Angela, et al.
Publicado: (2011)

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
por: Boers, Maarten, et al.
Publicado: (2022)

Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study
por: Tam, Lai-Shan, et al.
Publicado: (2007)

Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
por: Pincus, T, et al.
Publicado: (2009)

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
por: Hobbs, Kathryn, et al.
Publicado: (2015)

Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study
por: Tahir, Hasan, et al.
Publicado: (2017)

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis
por: Wang, Yiru, et al.
Publicado: (2019)

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor Therapy
por: Frenken, Miriam, et al.
Publicado: (2023)

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Copper Bracelets and Magnetic Wrist Straps for Rheumatoid Arthritis – Analgesic and Anti-Inflammatory Effects: A Randomised Double-Blind Placebo Controlled Crossover Trial
por: Richmond, Stewart J., et al.
Publicado: (2013)

Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
por: Kåss, AS, et al.
Publicado: (2014)

Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial
por: Tang, Yujun, et al.
Publicado: (2022)

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Placebo-Related Adverse Events in Rheumatoid Arthritis
por: Sharma, Ratna Shree, et al.
Publicado: (2022)

Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
por: Schiff, M, et al.
Publicado: (2008)

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
por: Fleishaker, Dona L, et al.
Publicado: (2012)

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
por: Peterfy, Charles, et al.
Publicado: (2016)

Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial
por: van Vollenhoven, R. F., et al.
Publicado: (2015)

The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial
por: Lee, Seunghoon, et al.
Publicado: (2018)

TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
por: Niemantsverdriet, Ellis, et al.
Publicado: (2020)

Leptomeningeal inflammation in rheumatoid arthritis
por: Lattanzi, Simona, et al.
Publicado: (2014)

Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study
por: Wahlin, Bengt, et al.
Publicado: (2016)

Treatment of Rheumatoid Arthritis with Marine and Botanical Oils: An 18-Month, Randomized, and Double-Blind Trial
por: Reed, George W., et al.
Publicado: (2014)

Lipid abnormalities in patients with Rheumatoid Arthritis
por: Erum, Uzma, et al.
Publicado: (2017)

The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis
por: Kivitz, Alan, et al.
Publicado: (2023)

Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: A randomized placebo-controlled clinical trial
por: Vaghef-Mehrabany, Elnaz, et al.
Publicado: (2017)

Subclinical coronary artery disease in recent-onset of rheumatoid arthritis
por: Jawad, Ali S. M.
Publicado: (2019)

Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial
por: Moludi, Jalal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1bnic1pak3heb61s01n371ras